BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 29852467)

  • 41. Generation and characterization of two iPSC lines from human epicardium-derived cells.
    Paulitschek C; Schulze-Matz P; Hesse J; Schmidt T; Wruck W; Adjaye J; Schrader J
    Stem Cell Res; 2017 Apr; 20():50-53. PubMed ID: 28395740
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Generation of an induced pluripotent stem cell line (XHCSUi001-A) from urine cells of a patient with spinocerebellar ataxia type 3.
    He L; Ye W; Chen Z; Wang C; Zhao H; Li S; Peng L; Han X; Zhou T; Li Z; Tang B; Jiang H
    Stem Cell Res; 2019 Oct; 40():101555. PubMed ID: 31491691
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Generation of two Alpha-I antitrypsin deficiency patient-derived induced pluripotent stem cell lines ISRM-AATD-iPSC-1 (HHUUKDi011-A) and ISRM-AATD-iPSC-2 (HHUUKDi012-A).
    Ncube A; Bewersdorf L; Spitzhorn LS; Loerch C; Bohndorf M; Graffmann N; May L; Amzou S; Fromme M; Wruck W; Strnad P; Adjaye J
    Stem Cell Res; 2023 Sep; 71():103171. PubMed ID: 37506509
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Fibroblast-derived integration-free iPSC line ISRM-NBS1 from an 18-year-old Nijmegen Breakage Syndrome patient carrying the homozygous NBN c.657_661del5 mutation.
    Martins S; Bohndorf M; Graffmann N; Wruck W; Chrzanowska KH; Adjaye J
    Stem Cell Res; 2019 Jan; 34():101372. PubMed ID: 30616142
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Generation of two induced pluripotent stem cell lines from a patient with compound heterozygous mutations in the USH2A gene.
    McLenachan S; Wong EYM; Zhang X; Leith F; Moon SY; Zhang D; Chen SC; Thompson JA; McLaren T; Lamey T; De Roach JN; Atlas MD; Dilley RJ; Chen FK
    Stem Cell Res; 2019 Apr; 36():101420. PubMed ID: 30904819
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Generation of induced pluripotent stem cells from buffalo (Bubalus bubalis) fetal fibroblasts with buffalo defined factors.
    Deng Y; Liu Q; Luo C; Chen S; Li X; Wang C; Liu Z; Lei X; Zhang H; Sun H; Lu F; Jiang J; Shi D
    Stem Cells Dev; 2012 Sep; 21(13):2485-94. PubMed ID: 22420535
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Generation of induced pluripotent stem cells from peripheral blood CD34+ hematopoietic progenitors of a 31year old healthy woman.
    Tangprasittipap A; Jittorntrum B; Wongkummool W; Kitiyanant N; Tubsuwan A
    Stem Cell Res; 2017 Apr; 20():91-93. PubMed ID: 28395748
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Generation of the human induced pluripotent stem cell line PUMCi005-A from a patient with Perrault syndrome.
    Wang YB; Lv YF; Zhang Y; Wang W
    Stem Cell Res; 2024 Mar; 75():103318. PubMed ID: 38295749
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reprogramming of dermal fibroblasts from a Duchenne muscular dystrophy patient carrying a deletion of exons 45-50 into an induced pluripotent stem cell line (CCMi005-A).
    Rovina D; Castiglioni E; Mallia S; Rabino M; Farini A; Belicchi M; Di Giuseppe G; Gervasini C; Torrente Y; Pompilio G; Gowran A
    Stem Cell Res; 2022 Oct; 64():102889. PubMed ID: 35961103
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Derivation of human induced pluripotent stem cell line (HUSTi001-A) from a 40-year-old patient with idiopathic infertility.
    Fang F; Li Z; Zhao Q; Ye Z; Zhao K; Gu X; Shen S; Reijo Pera RA; Xiong C
    Stem Cell Res; 2018 Mar; 27():136-139. PubMed ID: 29414604
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Generation of iPSC line MU011.A-hiPS from homozygous α-thalassemia fetal skin fibroblasts.
    Tangprasittipap A; Satirapod C; Jittorntrum B; Lertritanan S; Anurathaphan U; Phanthong P; Borwornpinyo S; Kitiyanant N; Hongeng S
    Stem Cell Res; 2015 Nov; 15(3):506-9. PubMed ID: 26432158
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Induced pluripotent stem cell - derived neurons for the study of spinocerebellar ataxia type 3.
    Hansen SK; Stummann TC; Borland H; Hasholt LF; Tümer Z; Nielsen JE; Rasmussen MA; Nielsen TT; Daechsel JC; Fog K; Hyttel P
    Stem Cell Res; 2016 Sep; 17(2):306-317. PubMed ID: 27596958
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Generation of an isogenic, gene-corrected control cell line of the spinocerebellar ataxia type 2 patient-derived iPSC line H266.
    Marthaler AG; Tubsuwan A; Schmid B; Poulsen UB; Engelbrecht AF; Mau-Holzmann UA; Hyttel P; Nielsen TT; Nielsen JE; Holst B
    Stem Cell Res; 2016 Jan; 16(1):202-5. PubMed ID: 27345815
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Establishment and characterization of human induced pluripotent stem cell line from a Parkinson's disease patient harboring VPS13A gene mutation.
    Lu X; Wang W; Liu Y; Song N; Li M; Mu X; Zhang N; Chen Q; Jiang L; Kong X; Sun P; Tong J; Zhang Y; Li J; Ma S; Han F
    Stem Cell Res; 2022 Apr; 60():102685. PubMed ID: 35093716
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Generation of an isogenic, gene-corrected control cell line of the spinocerebellar ataxia type 2 patient-derived iPSC line H271.
    Marthaler AG; Schmid B; Tubsuwan A; Poulsen UB; Engelbrecht AF; Mau-Holzmann UA; Hyttel P; Nielsen JE; Nielsen TT; Holst B
    Stem Cell Res; 2016 Jan; 16(1):180-3. PubMed ID: 27345809
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Generation of an isogenic, gene-corrected control cell line of the spinocerebellar ataxia type 2 patient-derived iPSC line H196.
    Marthaler AG; Schmid B; Tubsuwan A; Poulsen UB; Engelbrecht AF; Mau-Holzmann UA; Hyttel P; Nielsen JE; Nielsen TT; Holst B
    Stem Cell Res; 2016 Jan; 16(1):162-5. PubMed ID: 27345804
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Generation and characterization of a genetic Parkinson's disease-patient derived iPSC line DJ-1-delP (LCSBi008-A).
    Mencke P; Boussaad I; Önal G; Kievit AJA; Boon AJW; Mandemakers W; Bonifati V; Krüger R
    Stem Cell Res; 2022 Jul; 62():102792. PubMed ID: 35500378
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lymphoblast-derived integration-free iPSC line AD-TREM2-1 from a 67year-old Alzheimer's disease patient expressing the TREM2 p.R47H variant.
    Martins S; Yigit H; Bohndorf M; Graffmann N; Fiszl AR; Wruck W; Sleegers K; Van Broeckhoven C; Adjaye J
    Stem Cell Res; 2018 May; 29():60-63. PubMed ID: 29602048
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Generation of human iPSCs from cells of fibroblastic and epithelial origin by means of the oriP/EBNA-1 episomal reprogramming system.
    Drozd AM; Walczak MP; Piaskowski S; Stoczynska-Fidelus E; Rieske P; Grzela DP
    Stem Cell Res Ther; 2015 Jun; 6(1):122. PubMed ID: 26088261
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lymphoblast-derived integration-free ISRM-CON9 iPS cell line from a 75year old female.
    Martins S; Bohndorf M; Schröter F; Assar F; Wruck W; Sleegers K; Van Broeckhoven C; Adjaye J
    Stem Cell Res; 2018 Jan; 26():76-79. PubMed ID: 29268155
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.